Life Sciences


1 to 10 of 432
  • Evidence gathering: Part 1

    Conference Call

    Submitted: 02 July 2015

    This session discusses the practicalities of documentary evidence gathering, efficient analysis of that evidence and the expectations of the regulators.

  • New attempts to fight corruption in the German health care sector


    Last Reviewed: 03 July 2015 / Submitted: 05 June 2015

    Upcoming legislative changes threatening practices in the German life sciences sector.

  • Episode 0479: Recent pharmaceutical antitrust cases in France

    Video Podcast

    Submitted: 05 June 2015

    Ombline Ancelin, partner in the Simmons & Simmons Paris office, discusses recent and ongoing competition cases in the pharmaceutical sector in France with Genevieve Borremans, associate in the Brussels office.

  • 统一专利适合谁?


    Last Reviewed: 02 June 2015 / Submitted: 02 June 2015


  • Compliance in Germany - data privacy

    Conference Call

    Submitted: 20 May 2015

    This session provided an overview of what data privacy is all about in Germany and the most common pitfalls to be aware of.​

  • Italy prepares to join the Unitary Patent Restricted access


    Submitted: 15 May 2015

    Italy is preparing to join the Unitary Patent​, having previously expressed scepticism.

  • The Big Bus Company v Ticketogo case update


    Submitted: 14 May 2015

    Negotiating patent licences – might pre-Action disclosure help?

  • Brevetti e accesso ai farmaci nei Paesi in via di sviluppo


    Submitted: 11 May 2015

    Il recente accordo tra Gilead e alcune aziende indiane per la produzione su licenza di sofosbuvir e ledipasvir ripropone l’eterna difficoltà di conciliare la tutela della proprietà industriale e la disponibilità di cure a basso costo nei Paesi dov’è maggiore l’emergenza sanitaria. Nel presente articolo, già pubblicato su AboutPharma del mese di marzo 2015, si propongono alcune riflessioni sul tema.

  • The Unitary Patent - who is it for?


    Last Reviewed: 13 May 2015 / Submitted: 06 May 2015

    The Unitary Patent is coming - who will choose to have its coverage?​

  • China issues amendment to the Drug Administration Law Restricted access


    Last Reviewed: 29 April 2015 / Submitted: 29 April 2015

    China promulgated the Amendment to the Drug Administration Law, which eases the incorporation process for drug companies and removes certain price restrictions.

1 to 10 of 432